Biogen’s Aducanumab Administered to Chinese Patient for First Time
US major Biogen’s (NASDAQ: BIIB) Alzheimer’s disease (AD) therapy aducanumab has been administered to a...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity
US major Biogen’s (NASDAQ: BIIB) Alzheimer’s disease (AD) therapy aducanumab has been administered to a...